SCHEMBL3560759

SCHEMBL3560759

CCCCN(c1ccccc1CCc1ccc(C(=O)O)cc1)S(=O)(=O)c1cccc(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.48
PTGER1 P34995 1/20 0.47
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PTGES O14684 3/20 0.45
TAS2R14 Q9NYV8 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CNR2 P34972 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3568000 0.96 ALOX5 (0.50) ALOX5PTGER1LMNAMEN1KMT2A
SCHEMBL3560865 0.91 ALOX5 (0.57) ALOX5LMNAMEN1KMT2APTGES
SCHEMBL3561608 0.90 TAS2R14 (0.48) ALOX5LMNAMEN1KMT2APTGES
SCHEMBL3558490 0.89 ALOX5 (0.56) ALOX5PTGER1LMNAMEN1KMT2A
SCHEMBL3560770 0.88 PTGER2 (0.51) ALOX5PTGER1TAS2R14L3MBTL1SMN1; SMN2
SCHEMBL3559141 0.87 MEN1 (0.48) ALOX5PTGER1LMNAMEN1KMT2A
SCHEMBL3564284 0.87 ALOX5 (0.58) ALOX5LMNAMEN1KMT2APTGES
SCHEMBL3555271 0.87 ALOX5 (0.59) ALOX5LMNAMEN1KMT2APTGES
SCHEMBL3557378 0.87 ALOX5 (0.58) ALOX5LMNAMEN1KMT2APTGES
SCHEMBL3552576 0.86 SLC16A3 (0.55) ALOX5PTGESTAS2R14L3MBTL1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 ALOX5 101/4885PTGER1 39/4885LMNA 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.